Myriad Genetics is a genetic testing and precision medicine company. It specializes its products, capabilities, and expertise in three areas: oncology, women's health, and mental health. The company develops molecular diagnostic tests designed to analyze genes and their expression levels to assess an individual’s risk for developing disease, determine a patient’s likelihood of responding to a particular drug, or assess a patient’s risk of disease progression.